# Harmony Biosciences Holdings, Inc.: filings

HRMY · Nasdaq · CIK 1802665 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hrmy.md) · [Financials](/companies/hrmy/financials.md) · [Filings](/companies/hrmy/filings.md) · [Insiders](/companies/hrmy/insiders.md)

## Reports and events: 115 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 182, 8-K 73, 144 43, 3 24, SC 13G/A 20, 10-Q 18, SC 13G 9, SCHEDULE 13G/A 7, 10-K 6, 8-K/A 6, CORRESP 6, DEF 14A 6, DEFA14A 6, 4/A 5, S-8 5, UPLOAD 5, ARS 4, SC TO-T/A 4, S-1/A 3, 3/A 2, 424B7 2, S-3ASR 2, SC TO-C 2, 10-K/A 1, 424B4 1, 424B5 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, EFFECT 1, S-1 1, S-1MEF 1, SC 13D 1, SCHEDULE 13G 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:15 ET | [8-K/A](/filings/0001104659-26-120673.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-120673 |
| 2026-10-13 | 08:00 ET | [8-K](/filings/0001104659-26-115282.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115282 |
| 2026-08-04 | 08:16 ET | [10-Q](/filings/0001104659-26-090090.md) | Quarterly report, period 2026-06-30 | 0001104659-26-090090 |
| 2026-08-04 | 08:05 ET | [8-K](/filings/0001104659-26-090086.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-090086 |
| 2026-07-16 | 08:35 ET | [8-K](/filings/0001104659-26-084095.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-084095 |
| 2026-05-14 | 16:31 ET | [8-K](/filings/0001104659-26-061237.md) | 5.07 Shareholder vote results | 0001104659-26-061237 |
| 2026-05-07 | 09:24 ET | [8-K](/filings/0001104659-26-056786.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-056786 |
| 2026-05-07 | 08:16 ET | [10-Q](/filings/0001104659-26-056720.md) | Quarterly report, period 2026-03-31 | 0001104659-26-056720 |
| 2026-04-14 | 08:15 ET | [8-K](/filings/0001104659-26-042886.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-042886 |
| 2026-04-03 | 08:00 ET | [DEF 14A](/filings/0001104659-26-039449.md) | Proxy statement, period 2026-05-14 | 0001104659-26-039449 |
| 2026-04-02 | 08:15 ET | [8-K](/filings/0001104659-26-038888.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-038888 |
| 2026-02-24 | 08:16 ET | [10-K](/filings/0001104659-26-018859.md) | Annual report, period 2025-12-31 | 0001104659-26-018859 |
| 2026-02-24 | 08:10 ET | [8-K](/filings/0001104659-26-018858.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-018858 |
| 2026-01-12 | 08:20 ET | [8-K](/filings/0001104659-26-002731.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002731 |
| 2025-11-04 | 08:42 ET | [10-Q](/filings/0001104659-25-105962.md) | Quarterly report, period 2025-09-30 | 0001104659-25-105962 |
| 2025-11-04 | 08:05 ET | [8-K](/filings/0001104659-25-105942.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-105942 |
| 2025-10-23 | 08:15 ET | [8-K](/filings/0001104659-25-101688.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-101688 |
| 2025-09-24 | 08:39 ET | [8-K](/filings/0001104659-25-092776.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-092776 |
| 2025-08-05 | 08:16 ET | [10-Q](/filings/0001558370-25-010185.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010185 |
| 2025-08-05 | 08:00 ET | [8-K](/filings/0001558370-25-010182.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-010182 |
| 2025-06-11 | 08:30 ET | [8-K](/filings/0001558370-25-008525.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-008525 |
| 2025-06-05 | 08:30 ET | [8-K](/filings/0001558370-25-008415.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-008415 |
| 2025-05-15 | 16:30 ET | [8-K](/filings/0001558370-25-007894.md) | 5.07 Shareholder vote results | 0001558370-25-007894 |
| 2025-05-06 | 08:15 ET | [10-Q](/filings/0001558370-25-006394.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006394 |
| 2025-05-06 | 08:00 ET | [8-K](/filings/0001558370-25-006393.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006393 |
| 2025-04-04 | 16:17 ET | [DEF 14A](/filings/0001140361-25-012336.md) | Proxy statement, period 2025-05-15 | 0001140361-25-012336 |
| 2025-04-03 | 08:15 ET | [8-K](/filings/0001558370-25-004358.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-004358 |
| 2025-03-24 | 08:15 ET | [8-K](/filings/0001558370-25-003502.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-003502 |
| 2025-02-25 | 08:00 ET | [10-K](/filings/0001558370-25-001441.md) | Annual report, period 2024-12-31 | 0001558370-25-001441 |
| 2025-02-25 | 07:45 ET | [8-K](/filings/0001558370-25-001439.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-001439 |
| 2025-01-13 | 08:15 ET | [8-K](/filings/0001558370-25-000157.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-000157 |
| 2024-11-01 | 16:06 ET | [8-K](/filings/0001104659-24-113484.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-113484 |
| 2024-10-29 | 08:00 ET | [10-Q](/filings/0001558370-24-013803.md) | Quarterly report, period 2024-09-30 | 0001558370-24-013803 |
| 2024-10-29 | 07:50 ET | [8-K](/filings/0001558370-24-013802.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013802 |
| 2024-10-01 | 08:45 ET | [8-K](/filings/0001558370-24-013103.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013103 |
| 2024-08-06 | 08:15 ET | [8-K](/filings/0001558370-24-010960.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-010960 |
| 2024-08-06 | 08:00 ET | [10-Q](/filings/0001558370-24-010956.md) | Quarterly report, period 2024-06-30 | 0001558370-24-010956 |
| 2024-07-01 | 16:15 ET | [8-K](/filings/0001558370-24-009642.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-009642 |
| 2024-05-29 | 17:01 ET | [8-K](/filings/0001558370-24-008734.md) | 5.07 Shareholder vote results | 0001558370-24-008734 |
| 2024-05-03 | 08:00 ET | [8-K](/filings/0001558370-24-006594.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-006594 |
| 2024-04-30 | 08:00 ET | [10-Q](/filings/0001558370-24-006203.md) | Quarterly report, period 2024-03-31 | 0001558370-24-006203 |
| 2024-04-30 | 07:45 ET | [8-K](/filings/0001558370-24-006200.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-006200 |
| 2024-04-11 | 08:30 ET | [8-K](/filings/0001558370-24-004945.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-004945 |
| 2024-04-11 | 08:17 ET | [DEF 14A](/filings/0001140361-24-019230.md) | Proxy statement, period 2024-05-29 | 0001140361-24-019230 |
| 2024-02-28 | 17:16 ET | [10-K/A](/filings/0001558370-24-002037.md) | Annual report, amended, period 2023-12-31 | 0001558370-24-002037 |
| 2024-02-22 | 08:00 ET | [10-K](/filings/0001558370-24-001466.md) | Annual report, period 2023-12-31 | 0001558370-24-001466 |
| 2024-02-22 | 07:45 ET | [8-K](/filings/0001558370-24-001465.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-001465 |
| 2024-01-08 | 08:30 ET | [8-K](/filings/0001558370-24-000128.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-000128 |
| 2023-12-07 | 16:06 ET | [8-K/A](/filings/0001558370-23-019624.md) | 9.01 Financial statements and exhibits | 0001558370-23-019624 |
| 2023-11-08 | 08:30 ET | [8-K](/filings/0001558370-23-018125.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-018125 |

Page 1 of 3. [Older](/companies/hrmy/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:23 ET. No prices; not investment advice.